Search

Your search keyword '"Azimi, Parvin"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Azimi, Parvin" Remove constraint Author: "Azimi, Parvin" Database Unpaywall Remove constraint Database: Unpaywall
112 results on '"Azimi, Parvin"'

Search Results

1. Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015–2016 Through 2019–2020

2. Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification

3. 1178. Sustained Vaccine Effectiveness Against Influenza-Associated Hospitalization in Children: Evidence from the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020

4. Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015–2016

5. Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018

7. Contributors

8. Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016

9. Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015–2016

10. 2639. Respiratory Virus Detections in Asthma-Related Pediatric Hospitalizations: New Vaccine Surveillance Network, United States

11. 2328. Human Respiratory Syncytial Virus Subgroups among Hospitalized Infants in the United States, 2015–2016

12. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016

13. Infectious Causes of Acute Gastroenteritis in US Children Undergoing Allogeneic Hematopoietic Cell Transplant: A Longitudinal, Multicenter Study

14. Evidence for Household Transmission of Rotavirus in the United States, 2011–2016

15. Factors Associated With Rotavirus Vaccine Coverage

16. 721. Clinical Respiratory Syndromes and Association with Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness, 2015–2016

17. 1106. Infectious Etiologies of Acute Gastroenteritis in Children during the First 100 Days Post-Allogeneic Hematopoietic Cell Transplant

18. 751. Acute Respiratory Illness Hospitalizations Among Young Children: Multi-Center Viral Surveillance Network, United States, 2015–2016

19. Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children

20. Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness During the 2015–16 Influenza Season

21. Respiratory Syncytial Virus-Associated Hospitalizations in Young Children in the United States, 2015–2016

22. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008–2013

23. Viruses Associated With Acute Respiratory Illnesses (ARI) in Hospitalized Pediatric Patients 5-17 Years of Age in the United States

24. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012–2013

25. Suspected Household Transmission of Rotavirus in the United States

26. Antibiotic-Resistant Enterobacteriaceae Colonization in Healthy Children in the United States

27. Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011

28. Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods

30. Burden of Rotavirus Disease Among Children Visiting Pediatric Emergency Departments in Cincinnati, Ohio, and Oakland, California, in 1999–2000

32. Population Structure of Invasive and Colonizing Strains of Streptococcus agalactiae from Neonates of Six U.S. Academic Centers from 1995 to 1999

35. Phylogenetic Lineages of Invasive and Colonizing Strains of Serotype III Group B Streptococci from Neonates: a Multicenter Prospective Study

38. Level of Maternal IgG Anti–Group B Streptococcus Type III Antibody Correlated with Protection of Neonates against Early‐Onset Disease Caused by This Pathogen

40. Environmental Isolation of Balamuthia mandrillaris Associated with a Case of Amebic Encephalitis

43. Level of Maternal Antibody Required to Protect Neonates against Early‐Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study

46. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease

Catalog

Books, media, physical & digital resources